- Report
- January 2024
- 483 Pages
Global
From €7122EUR$7,150USD£6,017GBP
- Report
- October 2024
- 169 Pages
Global
From €2316EUR$2,325USD£1,957GBP
€4632EUR$4,650USD£3,913GBP
- Report
- October 2024
- 193 Pages
Global
From €3924EUR$3,939USD£3,315GBP
- Report
- October 2024
- 189 Pages
Global
From €3924EUR$3,939USD£3,315GBP
- Report
- January 2025
- 453 Pages
Global
From €5778EUR$5,800USD£4,881GBP
- Report
- January 2025
- 803 Pages
Global
From €5578EUR$5,600USD£4,713GBP
- Report
- January 2025
- 89 Pages
Global
From €5578EUR$5,600USD£4,713GBP
- Report
- February 2024
- 175 Pages
Global
From €4981EUR$5,000USD£4,208GBP
- Report
- December 2024
- 206 Pages
Global
From €2490EUR$2,500USD£2,104GBP
- Report
- October 2024
- 189 Pages
Global
From €3924EUR$3,939USD£3,315GBP
- Report
- October 2024
- 231 Pages
Global
From €5927EUR$5,950USD£5,007GBP
- Report
- December 2024
- 175 Pages
Global
From €4981EUR$5,000USD£4,208GBP
- Report
- October 2024
- 227 Pages
Global
From €5170EUR$5,190USD£4,368GBP
- Report
- December 2024
- 186 Pages
Global
From €4483EUR$4,500USD£3,787GBP
- Report
- July 2024
- 120 Pages
Global
From €4732EUR$4,750USD£3,997GBP
- Report
- August 2024
- 180 Pages
North America
From €3984EUR$3,999USD£3,365GBP
- Report
- September 2024
- 450 Pages
Global
From €3980EUR$3,995USD£3,362GBP
- Report
- September 2024
- 700 Pages
Global
From €3980EUR$3,995USD£3,362GBP
- Report
- August 2024
- 1000 Pages +
Global
From €3980EUR$3,995USD£3,362GBP
- Report
- August 2024
- 1500 Pages +
Global
From €3980EUR$3,995USD£3,362GBP
The Contract Research Organization (CRO) market within the biotechnology sector is a rapidly growing industry. It provides services to biotechnology companies, such as drug discovery, preclinical and clinical trials, and regulatory affairs. CROs are often used to outsource research and development activities, allowing biotechnology companies to focus on their core competencies. CROs also provide access to specialized expertise and resources, such as specialized laboratory equipment and personnel.
CROs are increasingly being used to reduce costs and speed up the development process. They are also used to reduce the risk associated with drug development, as they can provide access to a wide range of expertise and resources.
Some of the major companies in the CRO market include Parexel, Quintiles, Charles River Laboratories, Covance, and PRA Health Sciences. Show Less Read more